Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasion

11 Apr 2019

Abstract excerpt

BACKGROUND: Prostate cancer is the most common form of cancer in males and accounts for high cancer related deaths. Therapeutic advancement in prostate cancer has not been able to reduce the mortality burden of prostate cancer, which warrants further research. FRG1 which affects angiogenesis and cell migration in Xenopus, can be a potential player in tumorigenesis. In this study, we investigated the role of FRG1...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Prostate Cancer Diagnosis and Treatment
Share to Prostate Cancer Treatment and Research
Share to S100 Proteins and Annexins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30975102
DOI: 10.1186/s12885-019-5509-4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Reduced FRG1 expression promotes prostate cancer progression and affects prostate cancer cell migration and invasionPMID 30975102Read ↗

Investigation of the Effects of Galectin-1 on Enzalutamide Sensitivity and Cellular Functions in Prostate Cancer Cells and Its Clinical Diagnostic ValueSemantic proximity Read ↗

SPP1 Promotes Enzalutamide Resistance and EMT Activation in CRPC Progression via PI3K/AKT and ERK1/2 PathwaysSemantic proximity Read ↗

Evidence for distinct alterations in the FGF axis in prostate cancer progression to an aggressive clinical phenotype.Semantic proximity Read ↗

GATA2 as a potential metastasis-driving gene in prostate cancerSemantic proximity Read ↗

COL10A1 Facilitates Prostate Cancer Progression by Interacting With INHBA to Activate the PI3K / AKT PathwaySemantic proximity Read ↗

FGFR-4 Arg³⁸⁸ enhances prostate cancer progression via extracellular signal-related kinase and serum response factor signaling.Semantic proximity Read ↗

LINC00992 contributes to the oncogenic phenotypes in prostate cancer via targeting miR-3935 and augmenting GOLM1 expression.Semantic proximity Read ↗

Exploration of the influence of GOLGA8B on prostate cancer progression and resistance of castration-resistant prostate cancer to cabazitaxelSemantic proximity Read ↗

Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional StudiesSemantic proximity Read ↗

Selective over-expression of fibroblast growth factor receptors 1 and 4 in clinical prostate cancer.Semantic proximity Read ↗

Key Genes And Pathways Controlled By E2F1 In Human Castration-Resistant Prostate Cancer CellsSemantic proximity Read ↗

HIF-1α affects invasion and metastasis of prostate cancer by regulating invadopodia formationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.